Exscientia plc (EXAI) Investors with Losses are Urged to Contact Levi & Korsinsky to Discuss Their RightsAccesswire • 03/03/24
Did Exscientia plc Mislead Investors? Shareholder Rights Advocates at Levi & Korsinsky Investigate - EXAIAccesswire • 03/01/24
Exscientia plc (EXAI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged WrongdoingsBusiness Wire • 02/26/24
Exscientia Initiates Clinical Study to Further Evaluate Functional Precision Medicine Platform in Cancer PatientsBusiness Wire • 02/07/24
The Cutting Edge: 3 Stocks to Buy for the Next Generation of Biotech BreakthroughsInvestorPlace • 01/25/24
Professor Andrew L. Hopkins appointed Commander of the Order of the British Empire (CBE)Business Wire • 01/02/24
Wall Street Analysts See a 67.76% Upside in Exscientia PLC Sponsored ADR (EXAI): Can the Stock Really Move This High?Zacks Investment Research • 12/21/23
Exscientia Announces Expansion of its Current Collaboration with Sanofi to Include Existing Exscientia ProgrammeBusiness Wire • 12/21/23
Looking for the Next Big Thing? Add This AI Biotech to Your Watch List Right NowThe Motley Fool • 12/07/23
Exscientia Receives Open Philanthropy Grant to Explore New Therapeutic Approach for Pandemic InfluenzaBusiness Wire • 12/05/23
Wall Street Analysts Think Exscientia PLC Sponsored ADR (EXAI) Could Surge 68.03%: Read This Before Placing a BetZacks Investment Research • 12/01/23
Wall Street Analysts Believe Exscientia PLC Sponsored ADR (EXAI) Could Rally 76.12%: Here's is How to TradeZacks Investment Research • 11/15/23
Exscientia to Report Third Quarter 2023 Financial Results on November 9, 2023Business Wire • 11/02/23
Does Exscientia PLC Sponsored ADR (EXAI) Have the Potential to Rally 104.18% as Wall Street Analysts Expect?Zacks Investment Research • 10/30/23